---
schema_version: "secwatch.filing_event.v1"
accession: "0001779128-23-000025"
form_type: "8-K"
ticker: "SRTA"
cik: "0001779128"
company_name: "Strata Critical Medical, Inc."
filed_at: "2023-03-14T23:59:59+00:00"
generated_at: "2026-06-18T03:37:23.309896+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Blade Q4 revenue $38.1M (+55% YoY); FY revenue $146.1M (+118%)

## Summary
- Q4 revenue $38.1M, up 55% YoY; FY revenue $146.1M, up 118% YoY.
- Short Distance revenue up 51% in Q4; MediMobility Organ Transport revenue up 120% in Q4.
- Flight Profit increased 38% in Q4, driven by organic and inorganic growth.
- Completed first piloted EVA test flight in NYC with BETA Technologies.
- Management expects cash balance available for acquisitions; path to profitability.

## SEC filing metadata
- accession: 0001779128-23-000025
- form_type: 8-K
- ticker: SRTA
- cik: 0001779128
- company_name: Strata Critical Medical, Inc.
- filed_at: 2023-03-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779128/000177912823000025/0001779128-23-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779128/000177912823000025/blde-20230314.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001779128-23-000025
- JSON: https://secwatch.observer/filing/0001779128-23-000025.json
- Plain text: https://secwatch.observer/filing/0001779128-23-000025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.